Drugs / DTPa-HBV-IPV/Hib
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01457495 | Sep 1998 → Sep 1999 | diphtheria, haemophilus meningitis, hepatitis B virus infection, pertussis +2 | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPa-HBV-IPV/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01457495 ↗ |
| Known as | Infanrix-hexa | “DTPa-HBV-IPV/Hib (Infanrix-hexa™)” NCT01457495 ↗ |
| Modality | Vaccine | “DTPa-HBV-IPV/Hib (Infanrix hexa™) vaccine” NCT01457495 ↗ |